Literature DB >> 15044831

Increased susceptibility of herpes simplex virus-1 growth in phytohemagglutinin-activated T lymphocytes caused by upregulation of herpesvirus entry mediator A mRNA expression.

Phattamawan Chimma1, Chintana Chirathaworn, Parvapan Bhattarakosol.   

Abstract

OBJECTIVES: To study herpes simplex virus (HSV) growth in human T lymphocytes (Jurkat cells) with and without phytohemagglutinin (PHA) activation and to investigate the possible mechanism of viral growth.
METHODS: The levels of HSV-1 production and adsorption were determined by plaque titration assay. The number of HSV-1-infected cells was assayed using flow cytometry. The expression of herpesvirus entry mediator A (HveA) mRNA was detected by RT-PCR.
RESULTS: HSV-1 production as well as the number of HSV-1-infected Jurkat cells were enhanced after the cells were activated by PHA. Moreover, the amount of viral entry was demonstrated to increase in PHA-activated cells. An increase in HveA mRNA was observed in PHA-activated Jurkat cells.
CONCLUSIONS: We found that HSV-1 can replicate in human T lymphocytes, and the replication was increased following PHA activation. This finding may be due to an increase in viral entry via HveA receptor. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044831     DOI: 10.1159/000076637

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  2 in total

1.  Actin Polymerization Is Required for Filopodia Formation Supporting HSV-1 Entry into Activated T Cells.

Authors:  Thanayod Sasivimolrattana; Pokrath Hansasuta; Supang Maneesri Le Grand; Parvapan Bhattarakosol
Journal:  Curr Microbiol       Date:  2021-12-14       Impact factor: 2.188

2.  HIV-1 replication in HIV-infected individuals is significantly reduced when peripheral blood mononuclear cells are superinfected with HSV-1.

Authors:  Taneth Yamsuwan; Chintana Chirathaworn; Pokrath Hansasuta; Parvapan Bhattarakosol
Journal:  ScientificWorldJournal       Date:  2012-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.